Amphastar Pharmaceuticals, Inc. Public Float
Amphastar Pharmaceuticals, Inc. (AMPH) had Public Float of $632.56 million as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $632.56M.
- 2024-06-30: Entity Public Float $1.20B.
- 2023-06-30: Entity Public Float $1.49B.
- 2022-06-30: Entity Public Float $885.26M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $632.56M 10-K · filed 2026-02-26 |
| 2024-06-30 | $1.20B 10-K · filed 2025-03-03 |
| 2023-06-30 | $1.49B 10-K · filed 2024-02-29 |
| 2022-06-30 | $885.26M 10-K · filed 2023-03-01 |
| 2021-06-30 | $481.78M 10-K · filed 2022-03-11 |
| 2020-06-30 | $566.69M 10-K · filed 2021-03-15 |
| 2019-06-30 | $638.12M 10-K · filed 2020-03-16 |
| 2018-06-30 | $454.91M 10-K · filed 2019-03-15 |
| 2017-06-30 | $638.08M 10-K · filed 2018-03-14 |
| 2016-06-30 | $570.10M 10-K · filed 2017-03-15 |
| 2015-06-30 | $625.64M 10-K · filed 2016-03-15 |
| 2014-06-30 | $430.69M 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |